Welcome to the e-CCO Library!

P288: Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Macaluso, F.S.(1);Cappello, M.(2);Crispino, F.(2);Grova, M.(2);Privitera, A.C.(3);Piccillo, G.(3);Magnano, A.(4);Ferracane, C.(4);Belluardo, N.(5);Giangreco, E.(5);Fries, W.(6);Viola, A.(6);Di Mitri, R.(7);Mocciaro, F.(7);Camilleri, S.(8);Garufi, S.(8);Renna, S.(1);Casà, A.(1);Maida, M.(8);Orlando, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P289 Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Tavakoli1, U. Vollmer-Conna2, X. Vazquez Campos3, D. Hadzi-Pavlovic2, M. Grimm1

Created: Thursday, 30 January 2020, 10:12 AM
P289: A French nationwide prospective study on patients with Crohn’s disease and ulcerative colitis treated with Infliximab-biosimilar CT-P13 in a real-life setting: two-year follow-up of the ReFLECT study
Year: 2021
Source: ECCO'21 Virtual
Authors: Bouhnik, Y.(1);Nancey, S.(2);Assing, M.(3);Mammar, N.(3);Laharie, D.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P289: Cytomegalovirus reactivation in ulcerative colitis is related to severe inflammatory activity
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Zagorowicz*1, M. Bugajski*1, A. Mróz2, A. Pietrzak1, A. Magdziak3, P. Wieszczy4

Created: Friday, 22 February 2019, 9:49 AM
P289: Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project.
Year: 2022
Source: ECCO'22
Authors: Martin Cardona, A.(1,2);Horta, D.(1,2);Florez-Diez, P.(3);Vela , M.(4);Mesonero, F.(5);Ramos Belinchón, C.(6);García, M.J.(7);Masnou, H.(8);de la Peña-Negro, L.(9);Suárez Ferrer, C.(10);Casanova, M.J.(11);Ortiz Durán, M.(12);Peña, E.(13);Calvet, X.(14);Fernández Prada, S.J.(15);González-Muñoza, C.(16);Piqueras, M.(17);Rodríguez-Lago, I.(18);Sainz, E.(19);Bas-Cutrina, F.(20);Manceñido Marcos, N.(21);Ojeda, A.(22);Orts, B.(23);Sicilia, B.(24);Domènech, E.(8);Esteve, M.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P289: Hyperoxaluria in patients after ileocolic resection
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Navrátil, V.(1)*;Pipek, B.(1);Krivinka, J.(1);Gregar, J.(1);Kunovsky, L.(1);Falt, P.(1);
Created: Friday, 14 July 2023, 11:05 AM
P289: Outcome of endoscopic ally resected dysplasic lesions in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Saoula H.*1, Boutaleb A.2, Mahiou H.2, Aissaoui M.2, Salah A.2, Belhocine K.3, Bounab N.3, Hamidouche D.2, Gamar L.3, Aissat Y.2, Zmiri Y.2, Mitiche A.2, Osmane R.2, Kecili L.3, Berkane S.3, Boucekkine T.3, Amir Z.c.4, Nakmouche M.2

Created: Wednesday, 20 February 2019, 10:36 AM
P289: The initial development of a Chat-Bot for inflammatory bowel disease (IBD) patients for use in e-health applications
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Zand*1, A. Sharma1, Z. Stokes1, C. Reynolds1, D. Hommes1

Created: Friday, 22 February 2019, 9:41 AM
P289: Transcutaneous nonlinearity strain ultrasound differentiates early vs. advanced fibrotic intestine in vivo in the TNBS rat model and is feasible in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

L.A. Johnson1, J.R. Dillman2, J. Hamilton1, J.M. Rubin2, P.D. Higgins3*

Created: Thursday, 21 February 2019, 9:14 AM
P290 Long-term disease outcome of ulcerative colitis (UC) in South Ostrobothnia, Finland with a follow-up time of 25 years
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Kontola1, P. Oksanen2, H. Huhtala3, H. Tunturi-Hihnala1, A. Jussila4

Created: Thursday, 30 January 2020, 10:12 AM
P290: Compliance to vaccination guidelines in patients with immune-mediated inflammatory diseases: a cross-sectional, single-centre study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Coenen*1, D. Bertrand2, T. Vanhoutvin3, P. Verschueren4, P. De Haes3, P. De Munter5, S. Vermeire1, M. Ferrante1

Created: Friday, 22 February 2019, 9:41 AM
P290: Determination of small-bowel patency in Crohn’s disease - a prospective study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Santos1*, M. Silva1, H. Cardoso1, R. Cunha2, A. Peixoto1, R. Gaspar1, S. Lopes1, G. Macedo1

Created: Thursday, 21 February 2019, 9:14 AM
P290: Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, E.S.(1)*;Lee, J.W.(1);Kim, S.K.(1);Lee, H.S.(1);Lee, Y.J.(2);Kim, J.(2);Kim, K.O.(3);Jang, B.I.(3);Kim, E.Y.(4);Jung, Y.J.(1);Park, S.K.(5);Park, D.I.(5);Woo, D.(6);Jeong, S.(6);
Created: Friday, 14 July 2023, 11:05 AM
P290: Evaluation of patients with retained patency capsule
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Silva M., Cardoso H., Peixoto A., Marques M., Nunes A.C.-R., Lopes S., Magro F., Macedo G.

Created: Wednesday, 20 February 2019, 10:36 AM
P290: Impact of concomitant 5-aminosalicylic acid therapy on vedolizumab efficacy and safety in Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Ungaro, R.(1);Kadali, H.(2);Zhang, W.(3);Adsul, S.(4);Reinisch, W.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P290: Pre-operative anti-glycan antibodies and anti-glycan antibodies developing after pouch surgery in patients with ulcerative colitis correlate with pouch complications: a prospective longitudinal case series
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Goren*1, L. Yahav2, H. Tulchinsky3, 4, I. Dotan4, 5

Created: Friday, 22 February 2019, 9:49 AM
P290: Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
Year: 2022
Source: ECCO'22
Authors: Ferreiro Iglesias, R.(1);Porto Silva, M.S.(1);Marín, S.(2);Casanova, M.J.(3);Mañosa, M.(4);González-Muñoza, C.(5);de Francisco, R.(6);Caballol, B.(7);Arias, L.(8);Piqueras, M.(9);Zabana , Y.(10);Rivero, M.(11);Calvet, X.(12);Mesonero, F.(13);Varela Trastoy, P.(14);Busta Nistal, R.(15);Gomez Perosanz, R.(16);Vega, P.(17);Gonzalez Vivo, M.(18);Iborra, M.(19);Jimenez Marquez, L.(20);Madero, L.(21);Rodríguez-Lago, I.(22);Rodriguez Gonzalez , M.(23);Vera, I.(24);Ponferrada Diaz, A.(25);Vela, M.(26);Torrealba, L.(27);Van Domselaar, M.(28);Iglesias , E.(2);P. Gisbert, J.(3);Calafat, M.(4);García-Planella, E.(5);Perez-Martinez, I.(6);Ricart, E.(7);Sicilia , B.(8);Mena, R.(9);Nieto, L.(1);Domenech, E.(4);Barreiro-de Acosta, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P291 Diagnostic utility of the neutrophil-platelet rate (NeuPla) as a marker of activity in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.K. Yamamoto-Furusho MD- PhD1, E.A. Mendieta-Escalante2

Created: Thursday, 30 January 2020, 10:12 AM
P291: Can the prognostic index be a predicting factor for mortality and morbidity in intestinal resection of patients with ulcerative colitis?
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Chohno*, M. Uchino, T. Minagawa, R. Kuwahara, Y. Horio, H. Sasaki, T. Bando, Y. Takesue, H. Ikeuchi

Created: Thursday, 21 February 2019, 9:14 AM
P291: Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
Year: 2022
Source: ECCO'22
Authors: Ikeda, A.(1);Kunisaki, R.(1);Aoki, S.(2);Yaguchi, K.(1);Asami, S.(1);Furusawa, K.(1);Atsusaka, R.(1);Azuma, D.(1);Tsunoda, S.(1);Fujii, K.(1);Nishida, D.(1);Madarame, A.(1);Nishio, M.(1);Ogashiwa, T.(1);Nakamori, Y.(1);Fuse, M.(1);Daibo, S.(1);Araki, K.(1);Kimura, H.(1);Suzuki, R.(3);Go, H.(4);Saigusa, Y.(4);Maeda, S.(5);
Created: Friday, 11 February 2022, 3:52 PM